Quality indicators for colonoscopy
- PMID: 39177519
- DOI: 10.1016/j.gie.2024.04.2905
Quality indicators for colonoscopy
Conflict of interest statement
Disclosure The following authors disclosed financial relationships: D. K. Rex: Consultant for Olympus Corporation, Boston Scientific, Braintree Laboratories, Norgine, GI Supply, Medtronic, and Acacia Pharmaceuticals; research support from Olympus Corporation, Medivators, Erbe USA Inc, and Braintree Laboratories; shareholder in Satisfai Health. T. Kaltenbach: Consultant for Verily Life Sciences and Olympus Corporation. U. Ladabaum: Advisor for Universal Dx, Kohler Ventures, Vivante Health, and Lean Health; consultant for Freenome, Guardant, Neptune, Media EarlySign, and Medtronic. T. R. Levin: Research support from Freenome, Inc. A. Shaukat: Consultant for Iterative Health. F. A. Farraye: Consultant for AbbVie, Avalo Therapeutics, BMS, Braintree Labs, Fresenius Kabi, GI Reviewers, GSK, IBD Educational Group, Iterative Health, Janssen, Pharmacosmos, Pfizer, Sandoz Immunology, and Viatris; data and safety monitoring board for Lilly. S. Kane: Consultant for Boehringer Ingelheim, Bristol Meyers Squibb, InveniAI, Janssen, Fresenius Kabi, PredicatMed, Lilly, and Takeda; section editor for UpToDate. All other authors disclosed no financial relationships.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical